WEEKEND UPDATE
May 2, 2020
Dear Valued Reader,

It's official now, April was the best month for the stock market in at least 20 years -- the Nasdaq had a better month in the Summer of 2000, and those were certainly wild days, but for the broader market indices you have to go back to 1987, just before I turned 18 (no, I didn't care at all about investing at the time -- I was a lazy teenager, not a green-eyeshade prodigy).  Doesn't really feel like it's been a great month, though, does it?  Well, as we ride the emotions of crashes and bubbles, your friends at Stock Gumshoe are here to help explain the crazy stories we're being pitched from newsletterdom... so what'd you miss this week?
The most popular article on the week, and the most discussed, was about Jeff Brown's "FDA Fast Track" pitch for what he thinks will be a $6.8 billion miracle antibiotic -- miss that one?  Just click below to...

Sick of the volatility? Need a hand? VantagePoint is the industry's leader in artificial intelligence forecasting, and they have fine-tuned their technology for over 40 years to give you the best trading tool you can find. Don't rely on lagging indicators or past data. Don’t miss out on opportunities to profit, now or in the future. The economy will bounce back. Join this free live training session online to see for yourself!


Advertisement

We started out the week with a visit to the Canadian Fools, who were pitching a "triple down" stock that they like, 1/100th the size of Google and poised to bring fortunes raining down upon us... so what is it?  Thinkolator results here.

After that it was on to George Gilder, a real blast from the past -- he's got a pricey new subscription to sell, and in return he's promising a bunch of "15G stocks" (3X better than 5G... get it?)... our piece about that one is here.

Then it was on to the great dream among biotech investors:  The cure for Alzheimer's (sure, it would be even better for society... but imagine how much moola that would bring in?)... Dave Lashmet at Stansberry hinted at one stock that has the "first and best drugs" for this dreaded disease, we look at (and try to solve) that tease here.

I also shared a bonus Friday teaser solution this week -- since gold is on the lips of so many pitchmen today, what's up with those "Gold Placements" being touted by E.B. Tucker?  It's a story about warrants, which are always fun, so just click here for my thoughts on that one.

Finally, the Friday File came out for the Irregulars (when?  You guessed it, it was Friday!)  This week I look at some quarterly updates on a bunch of larger Real Money Portfolio holdings, some of which are looking really appealing here. I also dig much deeper into insurance stocks following Markel’s (MKL) update, had some of my concerns eased about another large holding that's wrapped up in COVID-19's impact on hospitals,and updated you on two partial sales for some profit taking... full details if you click below...


Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.